Evidence map›Paper›PMID 30767388›Full record

ArticleAddiction (Abingdon, England)2019

Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations.

Amy Peacock, Briony Larance, Raimondo Bruno, Sallie-Anne Pearson, Nicholas A Buckley, Michael Farrell, Louisa Degenhardt

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Addiction (Abingdon, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Reframing the Overdose Crisis: Stigma, Industry Influence, and the Politics of Abuse-Deterrent Opioids.International journal of social determinants of health and health services · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Amy PeacockNational Drug and Alcohol Research Centre, University of New South Wales Sydney, NSW, Australia.ORCID 0000-0002-5705-2026
Briony LaranceNational Drug and Alcohol Research Centre, University of New South Wales Sydney, NSW, Australia.
Raimondo BrunoNational Drug and Alcohol Research Centre, University of New South Wales Sydney, NSW, Australia.
Sallie-Anne PearsonCentre for Big Data Research in Health, University of New South Wales Sydney, NSW, Australia.
Nicholas A BuckleyFaculty of Pharmacy, University of Sydney, NSW, Australia.
Michael FarrellNational Drug and Alcohol Research Centre, University of New South Wales Sydney, NSW, Australia.ORCID 0000-0001-7008-8130
Louisa DegenhardtNational Drug and Alcohol Research Centre, University of New South Wales Sydney, NSW, Australia.ORCID 0000-0002-8513-2218

Funding

Using existing data to understand and ameliorate risk in opioid agonist therapyR01DA044170 · NIDA · UNIVERSITY OF NEW SOUTH WALES · PI DEGENHARDT, LOUISA · 2017 to 2019
$641k
NIDA NIH HHS R01 DA044170
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Abuse-Deterrent FormulationsOpioid-Related DisordersPrescription Drug MisuseHumansMarketingAbuse-Deterrent FormulationsAbuse deterrent formulationdependenceextra-medical useinjectingopioidoverdosepharmacoepidemiologypost-marketingstigmatamper

Identifiers

PMID30767388
PMCPMC6656581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.